Hosted on MSN1mon
Oppenheimer downgrades Apple, cites weakening iPhone sales and AI innovation worries
Apple’s shares are expected to drop Oppenheimer reduced its profits per share estimate for the year 2026 by 4% to $7.95 – less than the average estimate of $8.23. The company now thinks Apple ...
Dane DeHaan Joins ‘Neuromancer’ Apple TV+ Series
Dane DeHaan (American Primeval, Oppenheimer) has been tapped for a major recurring role opposite leads Callum Turner and ...
Apple Inc. (NASDAQ:AAPL) is Kavar Capital Partners Group LLC’s Largest Position
Kavar Capital Partners Group LLC cut its holdings in shares of Apple Inc. (NASDAQ:AAPL – Free Report) by 1.1% during the ...
‘Neuromancer’ Series at Apple Casts Dane DeHaan
Dane DeHaan is the latest addition to the cast of the "Neuromancer" series currently in the works at Apple TV+.
CRN17y
Apple Grows, But So Does Channel Conflict
"The stores offer customers a great experience for buying Macs, iPods and now iPhones," Peter Oppenheimer, Apple's chief financial officer, told analysts during a conference call to discuss the ...
MacStories12y
Apple Q3 2012 Results: $35 Billion Revenue, 26 Million iPhones, 17 Million iPads, 4 Million Macs Sold
Apple CFO Peter Oppenheimer, quoted from Apple’s Financial Results for Q3 2012: Looking ahead to the fourth fiscal quarter, we expect revenue of about $34 billion and diluted earnings per share of ...
MacStories12y
Apple Q1 2013 Results: $54.5 Billion Revenue, 47.8 Million iPhones, 22.9 Million iPads, 4.1 Million Macs Sold
“We’re pleased to have generated over $23 billion in cash flow from operations during the quarter,” said Peter Oppenheimer, Apple’s CFO. “We established new all-time quarterly records for iPhone and ...